Drug Delivery

US Army combat veteran Luis Alvarez has developed a new drug delivery technology that can convert recombinant proteins into material-binding variants.

How can we get macromolecules across the intestinal epithelial barrier?

Vectura has more than 20 years’ experience in helping customers bring inhaled medicines to the market.

Patient perspectives can make a huge difference when designing drug delivery devices that are truly fit for real-world use.

With the right partner to help you harness the many benefits, nasal delivery is not to be sniffed at.

Can prodrug payloads lead to a new dawn for antibody drug conjugates?

Celebrating the top pharma manufacturing technologies to be released during 2020.

What biosecurity risks do exo-microorganisms pose?

Sitting Down With… Will Downie, CEO of Vectura Group, UK, to discuss his career and passion for business.

Why drug developers should take a fresh look at long-acting dosage forms.